Telescope Innovations Corp.

Recent News

• Telescope Reports First Profitable Quarter: Fiscal Quarter 2, 2023

  Vancouver, British Columbia--(Newsfile Corp. - April 25, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the second fiscal quarter ended February 28, 2023. Just over one year after securing facilities, assembling a team, and outfitting a research laboratory, the Company posted its third consecutive quarter of revenue and delivered its first profitable quarter (Figure 1).

  2023-04-25 8:00 AM EDT
• Telescope Reports First Fiscal Quarter 2023 Results

  Vancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the first fiscal quarter ended November 30, 2022. The Company also announces its participation in investor events and technical conferences."We are pleased to report our second consecutive quarter of revenues. Telescope continues to build our customer base while implementing processes to...

  2023-02-08 8:00 AM EST
• Telescope Presents 2022 Fiscal Year Highlights and Investor Update

  Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, provides a financial and corporate update.KEY HIGHLIGHTSTelescope generated revenues of CAD $595,398 in its first full fiscal year of operation ending August 31, 2022 A new Master Services Agreement with Aqualung Carbon Capture Four investor outreach and client business development activities by the end of...

  2023-01-23 8:00 AM EST
• Telescope Announces Closing of $1.46 Million Non-Brokered Private Placement

  Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce that it has closed a non-brokered private placement (the "Offering").Upon closing of the Offering, the Company issued a total of 4,879,499 units ("Units") at a price of $0.30 per Unit for aggregate gross proceeds of $1,463,849. Each Unit consists of...

  2022-11-10 5:05 PM EST
• Telescope Announces Engagement with Natural Resources Canada to Develop Lithium Refinement Technology

  Vancouver, British Columbia--(Newsfile Corp. - October 24, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces that it has been contracted by Natural Resources Canada ("NRCan") to help develop a critical lithium refinement technology. Over 16 months, Telescope will collaborate with NRCan to build an autonomous, self-driving experimental platform. The goal of this platform is to boost the efficiency of...

  2022-10-24 8:00 AM EDT
• Second Nobel Prize Won by Telescope Innovations Advisor

  Vancouver, British Columbia--(Newsfile Corp. - October 6, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced chemical technologies, announced today that K. Barry Sharpless, a member of Telescope's Scientific Advisory Board, and W.M. Keck Professor of Chemistry at Scripps Research, was awarded the 2022 Nobel Prize in Chemistry. Prof. Sharpless shares the award with Carolyn Bertozzi of Stanford and Morten Meldal of the University of Copenhagen, Denmark for the development of...

  2022-10-06 11:00 AM EDT
• Telescope Welcomes Dr. Jeffrey Sherman as Chief Operating Officer

  Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce that Dr. Jeffrey Sherman has accepted the position of Chief Operating Officer of the Company. Jeff brings over thirty years of experience in the scientific instrument industry. He has worked with emerging technology startups, mid-sized companies, and internationally leading suppliers...

  2022-09-06 9:00 AM EDT
• Telescope Upgrades US Listing to OTCQB

  Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Telescope Innovations Corp. ("Telescope" or the "Company") (CSE: TELI), a chemical technology company, is pleased to report that Telescope's U.S. ticker symbol "TELIF" has been upgraded to trade on the OTCQB market effective September 1, 2022. It is anticipated that Telescope's upgraded listing to the OTCQB will provide greater liquidity and a more seamless trading experience for our U.S. shareholders. With enhanced reporting requirements and greater transparency required with the OTCQB...

  2022-09-01 8:30 AM EDT
• Telescope Completes Feasibility Research Project Funded by Pfizer

  Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Telescope Innovations Corp. (CSE: TELI) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces that it has completed a four-month feasibility project funded by Pfizer to explore the acceleration of pharmaceutical process development through the use of automation. To successfully complete this project, Telescope created a proof-of-concept robotic workflow leveraging its proprietary in-situ analytical technology and automation tools and examined...

  2022-08-10 8:30 AM EDT
• Telescope Inks Research Agreement with Standard Lithium

  Vancouver, British Columbia--(Newsfile Corp. - July 13, 2022) - Telescope Innovations Corp. (CSE: TELI) ("Telescope" or the "Company"), a chemical technology company, announces that it has signed a Master Service Agreement ("MSA") with Standard Lithium Ltd. ("SLI"). For the first project under this MSA, Telescope will receive funding for one year to evaluate the utilization and sequestration of CO2 within the lithium brine extraction and reinjection processes developed by SLI. This project bolsters Telescope's "Industries" division, which leverages unique lab automation...

  2022-07-13 8:30 AM EDT